Show Summary Details
Page of

Evidence-Based Pharmacotherapy for Alcohol Use Disorders 

Evidence-Based Pharmacotherapy for Alcohol Use Disorders
Chapter:
Evidence-Based Pharmacotherapy for Alcohol Use Disorders
Author(s):

Donald McNally

and Albert J. Arias

DOI:
10.1093/med/9780190920197.003.0017
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 June 2022

Pharmacotherapy is a vital component of alcohol use disorder (AUD) treatment. From a biopsychosocial perspective, the use of pharmacotherapy alone and in combination with various therapeutic and psychosocial modalities to reduce harmful drinking behaviors is supported by a strong evidence base. This chapter presents an overview of the use of both US Food and Drug Administration (FDA)-approved and off-label treatments for AUD, and it provides practical information and evidence for the use of pharmacotherapy. Comprehensive reviews of medications are undertaken with an emphasis on evidence-based practice and clinical utility to aid in the treatment of AUD and harmful drinking behaviors.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.